Stockholm - Delayed Quote SEK

Elicera Therapeutics AB (publ) (ELIC.ST)

5.12
+0.72
+(16.36%)
At close: May 9 at 5:29:42 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings --

Q4'22

0
 

Analyst Price Targets

4.20 Low
4.20 Average
5.12 Current
4.20

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----11
Avg. Estimate 00-0.30.2
Low Estimate 00-0.30.2
High Estimate 00-0.30.2
Year Ago EPS -----0.51-0.3

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----22
Avg. Estimate ----6.65M52.35M
Low Estimate ----3.6M26.8M
High Estimate ----9.7M77.9M
Year Ago Sales ----7.13M6.65M
Sales Growth (year/est) -----6.71%687.22%

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Current Estimate 00-0.30.2
7 Days Ago 00-0.50.6
30 Days Ago 00-0.50.6
60 Days Ago 00-1.081
90 Days Ago 00-1.08-0.34

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Up Last 7 Days ----1--
Up Last 30 Days ----1--
Down Last 7 Days ------1
Down Last 30 Days ------1

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ELIC.ST ----41.18%166.67%
S&P 500 13.21%3.09%8.02%13.76%

Related Tickers